Adjuvant Endocrine Therapy and Risk of Contralateral Breast Cancer among U.S. Women with Breast Cancer

IMPORTANCE: Within ten years after breast cancer diagnosis, 5% of patients develop contralateral primary breast cancer (CBC). Randomized trials have found that tamoxifen and aromatase inhibitors (AIs) reduce CBC risk. However, little is known about the magnitude and duration of protective effects wi...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:JAMA Oncol
Main Authors: Gierach, Gretchen L., Curtis, Rochelle E., Pfeiffer, Ruth M., Mullooly, Maeve, Ntowe, Estelle A., Hoover, Robert N., Nyante, Sarah J., Feigelson, Heather Spencer, Glass, Andrew G., de Gonzalez, Amy Berrington
Formato: Artigo
Idioma:Inglês
Publicado em: 2016
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5757540/
https://ncbi.nlm.nih.gov/pubmed/27711920
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamaoncol.2016.3340
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados